Cite
HARVARD Citation
Muniesa, C. et al. (2023). Brentuximab vedotin in the treatment of cutaneous T‐cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry. Journal of the European Academy of Dermatology and Venereology. pp. 57-64. [Online].